n,n-dimethylarginine has been researched along with Shock, Cardiogenic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hermansen, SE; How, OJ; Kalstad, T; Myrmel, T | 1 |
| Kielstein, JT; Sydow, K; Thum, T | 1 |
2 other study(ies) available for n,n-dimethylarginine and Shock, Cardiogenic
| Article | Year |
|---|---|
Inflammation and reduced endothelial function in the course of severe acute heart failure.
Topics: Acute Disease; Aged; Aged, 80 and over; Arginine; Biomarkers; Case-Control Studies; Endothelium, Vascular; Female; Heart Failure; Humans; Inflammation; Inflammation Mediators; Intercellular Adhesion Molecule-1; Interleukin-6; Interleukin-8; Male; Middle Aged; Prospective Studies; Shock, Cardiogenic; Vascular Cell Adhesion Molecule-1; Vasodilation | 2011 |
Tilarginine in patients with acute myocardial infarction and cardiogenic shock.
Topics: Arginine; Enzyme Inhibitors; Glomerular Filtration Rate; Humans; Myocardial Infarction; Nitric Oxide Synthase; Shock, Cardiogenic; Vasoconstrictor Agents | 2007 |